Scorpius Holdings, Inc. (SCPX)
OTCMKTS · Delayed Price · Currency is USD
0.0013
0.00 (0.00%)
Jan 7, 2026, 4:00 PM EST
Scorpius Holdings Market Cap
Scorpius Holdings has a market cap or net worth of $79.49 thousand as of January 8, 2026. Its market cap has decreased by -97.52% in one year.
Market Cap
79.49K
Enterprise Value
15.38M
Revenue
2.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 24, 2013, Scorpius Holdings's market cap has decreased from 58.15M to 79.49K, a decrease of -99.86%. That is a compound annual growth rate of -41.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 79.49K | 549.98% |
| Dec 31, 2025 | 12.23K | -99.24% |
| Dec 31, 2024 | 1.61M | -86.01% |
| Dec 29, 2023 | 11.48M | -44.42% |
| Dec 30, 2022 | 20.66M | -73.25% |
| Dec 31, 2021 | 77.23M | -36.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 527.53M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |